[{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"F1888L","cancerType":"Renal Clear Cell Carcinoma","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"27482884","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709K","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"23566546, 18000506, 25179728, 25130612, 23749122, 15710947","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172G","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"27292784, 28588020, 26553750","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R140Q","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"27292784, 28588020, 26553750","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719A","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","cancerType":"Histiocytosis","level":"3A","drugs":"Sorafenib","pmids":"24569458, 26566875","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","cancerType":"Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"23890088, 26324360, 24345920","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"S467L","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"LTT462, BVD-523, KO-947","pmids":"","abstracts":"Infante et al. Abstract# 2506, ASCO 2015 http://meetinglibrary.asco.org/content/145666-156"},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","cancerType":"Chronic Myelogenous Leukemia","level":"1","drugs":"Nilotinib, Dasatinib, Imatinib","pmids":"11287973, 12637609, 20525993, 20525995, 22160483, 11287972, 23502220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L747P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"22190593","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"S467L","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Y1003N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000360948","refSeq":"NM_001012338.2","entrezGeneId":4916,"gene":"NTRK3","variant":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501; Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581I","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466E","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000278616","refSeq":"NM_000051.3","entrezGeneId":472,"gene":"ATM","variant":"R3008C","cancerType":"Prostate Cancer","level":"4","drugs":"Olaparib","pmids":"26510020","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G380R","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"19553641, 20406929, 21862407, 25366685, 20609468","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600M","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"S768I","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"17285735, 15638953, 25521405, 14570950, 26051236, 18408761","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L858R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"15638953, 22452895, 25589191, 23816960, 14570950, 22285168, 20022809, 19692680, 21670455, 18408761, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581S","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000241453","refSeq":"NM_004119.2","entrezGeneId":2322,"gene":"FLT3","variant":"FLT3 internal tandem duplications","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Sorafenib","pmids":"18230792, 22368270","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650E","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000278616","refSeq":"NM_000051.3","entrezGeneId":472,"gene":"ATM","variant":"N2875K","cancerType":"Prostate Cancer","level":"4","drugs":"Olaparib","pmids":"26510020","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Fusions","cancerType":"Myelodysplasia","level":"1","drugs":"Imatinib","pmids":"12944919, 17555450, 12660384, 16498388, 14504092, 16845659, 15034867","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"EGFR-KDD Fusion","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"15638953, 14570950, 26286086, 18408761","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"T1977K","cancerType":"Renal Clear Cell Carcinoma","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"27482884","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"C1483F","cancerType":"Renal Clear Cell Carcinoma","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"27482884","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000311189","refSeq":"NM_001130442.1","entrezGeneId":3265,"gene":"HRAS","variant":"Oncogenic Mutations","cancerType":"Head and Neck Squamous Cell Carcinoma","level":"3A","drugs":"Tipifarnib","pmids":"12497061, 24240680","abstracts":"Ho et al. Abstract# TPS2618, JCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.TPS2618"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S249C","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594G","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"15638953, 22452895, 25589191, 23816960, 14570950, 22285168, 20022809, 19692680, 21670455, 18408761, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"Nilotinib, Imatinib, Ponatinib","pmids":"24359404, 26455322","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000219476","refSeq":"NM_000548.3","entrezGeneId":7249,"gene":"TSC2","variant":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"2A","drugs":"Everolimus","pmids":"16981987, 15595939, 24729041, 23312829, 10533067, 26540169, 23158522, 21047224, 17304050, 24143074","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","cancerType":"Well-Differentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 20601955, 26324739, 21610706","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719S","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 15118073, 26051236, 21670455, 18408761, 16011858, 16187797, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L833V","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21949883, 23912954, 25130612, 20808254, 21422421","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","cancerType":"Thyroid Cancer","level":"4","drugs":"Dabrafenib + Lapatinib","pmids":"28423638, 23365119","abstracts":"Sherman, et al. Abstract# 6085, JCO, 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.6085"},{"isoform":"ENST00000425967","refSeq":"NM_001174067.1","entrezGeneId":2260,"gene":"FGFR1","variant":"Amplification","cancerType":"Lung Squamous Cell Carcinoma","level":"3A","drugs":"AZD4547, JNJ-42756493, BGJ398, Debio1347","pmids":"27870574, 23082000","abstracts":"Voss, MH et al. Abstract# 2500, ASCO 2017 http://meetinglibrary.asco.org/record/144575/abstract"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1008_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","cancerType":"Embryonal Tumor","level":"3A","drugs":"Sonidegib","pmids":"24900187, 24523439","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596D","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","cancerType":"Low-Grade Serous Ovarian Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V459L","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"963_D1010splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Exon 20 insertions/deletions","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","cancerType":"Esophagogastric Cancer","level":"1","drugs":"Trastuzumab","pmids":"20728210","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","cancerType":"Cholangiocarcinoma","level":"3A","drugs":"BGJ-398, AZD4575, JNJ-42756493, Debio1347","pmids":"29182496, 24122810","abstracts":"Cleary et al. Abstract# 447, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155948/abstract"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861R","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594H","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132H","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594G","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650T","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650M","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132C","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000377045","refSeq":"NM_001654.4","entrezGeneId":369,"gene":"ARAF","variant":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Sorafenib","pmids":"24569458","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","cancerType":"Melanoma","level":"3A","drugs":"Binimetinib, Binimetinib + Ribociclib","pmids":"16273091, 28284557, 22983396","abstracts":"Schuler et al. Abstract #9519, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9519"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Y373C","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G464E","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"26343582, 28783719","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132S","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","cancerType":"CNS Cancer","level":"2A","drugs":"Everolimus","pmids":"16981987, 15595939, 24729041, 23312829, 10533067, 26540169, 23158522, 21047224, 17304050, 24143074","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","cancerType":"Breast Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597S","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581I","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600M","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469R","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"26343582, 28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000462284","refSeq":"NM_002392.5","entrezGeneId":4193,"gene":"MDM2","variant":"Amplification","cancerType":"Liposarcoma","level":"3A","drugs":"DS-3032b, RG7112","pmids":"23400593, 23084521","abstracts":"Gounder et al. Abstract# 2581, ASCO 2016 http://meetinglibrary.asco.org/content/166204-176"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V459L","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597Q","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Wildtype","cancerType":"Colorectal Cancer","level":"1","drugs":"Regorafenib, Panitumumab, Cetuximab","pmids":"20921462, 24739896, 20921465, 19339720, 15269313, 15677699, 17470858, 23177514","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"963_D1010splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27908594, 27717299, 28229583","abstracts":"McNeish, I. et al. Abstract# 5508, ASCO 2015 http://meetinglibrary.asco.org/content/150121-156"},{"isoform":"ENST00000380152","refSeq":"NM_000059.3","entrezGeneId":675,"gene":"BRCA2","variant":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"2A","drugs":"Olaparib","pmids":"19553641, 20406929, 21862407, 25366685, 20609468","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"R1","drugs":"Imatinib","pmids":"25905001, 17087936, 12949711, 24963404, 22718859, 15928335, 18955458, 23752188, 22745105, 15685537, 18794084","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"Binimetinib, Trametinib","pmids":"25801412, 23934108, 22805291, 24746704, 28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1007_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596R","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861Q","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 18408761, 21252719","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"E2014K","cancerType":"Bladder Cancer","level":"3A","drugs":"Everolimus","pmids":"24625776, 23551593","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"L861R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 18408761, 21252719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596R","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132Q","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719C","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 15118073, 26051236, 21670455, 18408761, 16011858, 16187797, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","cancerType":"Ovarian Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","cancerType":"Dermatofibrosarcoma Protuberans","level":"1","drugs":"Imatinib","pmids":"20439456, 21128251, 24963404, 15503291, 15746584, 15681532, 19620561","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"23371856, 24065731, 19536777, 24353160, 21764376, 18676761, 24893891, 23328547, 1867676, 15897572, 17686547","abstracts":""},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Cabozantinib","pmids":"27825636, 23533264","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"R248C","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466V","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Neratinib","pmids":"23220880","abstracts":"Hyman et al. Abstract# CT001, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/CT001"},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"S371C","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000371953","refSeq":"NM_000314.4","entrezGeneId":5728,"gene":"PTEN","variant":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"GSK2636771, AZD8186","pmids":"18594509, 22588880, 25398829, 16647110, 25544636","abstracts":"Arkenau et al. Abstract# 2514, ASCO 2014 http://hwmaint.meeting.ascopubs.org/cgi/content/abstract/32/15_suppl/2514"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466V","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D287H","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000277541","refSeq":"NM_017617.3","entrezGeneId":4851,"gene":"NOTCH1","variant":"Gain-of-function Mutations","cancerType":"All Tumors","level":"4","drugs":"PF-03084014","pmids":"22504949, 23402814, 22806875, 22521243, 23408105, 20530712, 25231399, 24781018","abstracts":""},{"isoform":"ENST00000360948","refSeq":"NM_001012338.2","entrezGeneId":4916,"gene":"NTRK3","variant":"G696A","cancerType":"All Tumors","level":"4","drugs":"LOXO-195","pmids":"28578312","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469A","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"26343582, 28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1006_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000318560","refSeq":"NM_005157.4","entrezGeneId":25,"gene":"ABL1","variant":"BCR-ABL1 Fusion","cancerType":"Acute Lymphoid Leukemia","level":"1","drugs":"Dasatinib, Imatinib","pmids":"17496201, 11287973, 20131302, 12200353","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X963_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600M","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000277120","refSeq":"NM_006180.3","entrezGeneId":4915,"gene":"NTRK2","variant":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501; Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A750P","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"19625781, 25179728, 15737014","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"981_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Exon 20 insertions","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466E","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000320356","refSeq":"NM_004456.4","entrezGeneId":2146,"gene":"EZH2","variant":"Oncogenic Mutations","cancerType":"Diffuse Large B-Cell Lymphoma","level":"4","drugs":"Tazemetostat","pmids":"24563539, 23051747","abstracts":"Ribrag et al. American Society of Hematology 2015 http://www.bloodjournal.org/content/126/23/473?sso-checked=true"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594H","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"E709_T710delinsD","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Afatinib, Erlotinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 18408761, 26206867","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"20619739, 24024844, 25110411, 24024839","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"p61BRAF-V600E","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"22663011, 22113612","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597V","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469E","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 deletion/insertion","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"15638953, 22452895, 25589191, 23816960, 14570950, 22285168, 20022809, 19692680, 21670455, 18408761, 22370314, 20573926","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","cancerType":"Thyroid Cancer","level":"4","drugs":"Dabrafenib + Lapatinib","pmids":"28423638, 23365119","abstracts":"Sherman, et al. Abstract# 6085, JCO, 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.6085"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600D","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000331920","refSeq":"NM_000264.3","entrezGeneId":5727,"gene":"PTCH1","variant":"Truncating Mutations","cancerType":"Skin Cancer, Non-Melanoma","level":"3A","drugs":"Sonidegib, Vismodegib","pmids":"24900187, 22670903, 22670904, 24523439","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"R1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"24478319, 26051236, 23816963","abstracts":"Yang et al. Abstract# O03.05, IASLC 2013 http://library.iaslc.org/search-speaker?search_speaker=17991"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Imatinib, Sunitinib","pmids":"18235121, 12181401, 17046465, 19282169, 25641662, 16098458, 15451219, 23177515","abstracts":"von Mehren et al. Abstract# 10016, ASCO 2011 http://meetinglibrary.asco.org/content/82574-102"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"Fusions","cancerType":"Melanoma","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"26314551, 23890088, 24345920, 26072686","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Cabozantinib","pmids":"27279544, 27462141","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"Amplification","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"21623265","abstracts":"Camidge et al. Abstract# 8001, ASCO 2014 http://meetinglibrary.asco.org/content/132030-144"},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"D842V","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Dasatinib","pmids":"15928335, 18794084, 17419150","abstracts":"Trent et al. Abstract# 10006, ASCO 2011 http://meetinglibrary.asco.org/content/79120-102"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"19461405, 25592632, 20571495","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"LY3214996, KO-947, GDC-0994","pmids":"22805291, 15483017, 28783719","abstracts":"Robarge et al. Abstract# DDT02-03, AACR 2014 http://cancerres.aacrjournals.org/content/74/19_Supplement/DDT02-03"},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"FIP1L1-PDGFRA Fusion","cancerType":"Leukemia","level":"1","drugs":"Imatinib","pmids":"16754777, 12781364, 19212337, 12660384, 24963404, 14504092, 24407160, 27021554, 22745105, 21224473","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650Q","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816V","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000345146","refSeq":"NM_005896.2","entrezGeneId":3417,"gene":"IDH1","variant":"R132G","cancerType":"Acute Myeloid Leukemia","level":"3A","drugs":"Ivosidenib","pmids":"23393090, 23558169","abstracts":"Hansen et al. Abstract# 3734, ASH 2014 http://www.bloodjournal.org/content/124/21/3734?sso-checked=true"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G464V","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"26343582, 28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"T790M","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Osimertinib","pmids":"25923549","abstracts":""},{"isoform":"ENST00000358487","refSeq":"NM_000141.4","entrezGeneId":2263,"gene":"FGFR2","variant":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, AZD4575, JNJ-42756493, Debio1347","pmids":"26324363, 27870574, 24122810","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172M","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"27292784, 28588020, 26553750","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"S768I","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000397938","refSeq":"NM_005243.3","entrezGeneId":2130,"gene":"EWSR1","variant":"Fusions","cancerType":"Soft Tissue Sarcoma","level":"4","drugs":"TK216","pmids":"19584866","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","cancerType":"Inflammatory Myofibroblastic Tumor","level":"2A","drugs":"Crizotinib, Ceritinib","pmids":"24670165, 20979472, 23598171","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib","pmids":"23177515","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469E","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594N","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000357654","refSeq":"NM_007294.3","entrezGeneId":672,"gene":"BRCA1","variant":"Oncogenic Mutations","cancerType":"Ovarian Cancer","level":"1","drugs":"Rucaparib, Niraparib","pmids":"27908594, 27717299, 28229583","abstracts":"McNeish, I. et al. Abstract# 5508, ASCO 2015 http://meetinglibrary.asco.org/content/150121-156"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594A","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"L2230V","cancerType":"Renal Clear Cell Carcinoma","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"27482884","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G596D","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"A763_Y764insFQEA","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"15638953, 24353160, 14570950, 23969006, 18408761","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"T670I","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 19282169, 25641662, 23177515","abstracts":""},{"isoform":"ENST00000355710","refSeq":"NM_020975.4","entrezGeneId":5979,"gene":"RET","variant":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Vandetanib","pmids":"23578175, 25366691, 27803005, 23584301, 23991695, 23154560, 27825616","abstracts":""},{"isoform":"ENST00000381652","refSeq":"NM_004972.3","entrezGeneId":3717,"gene":"JAK2","variant":"PCM1-JAK2 Fusion","cancerType":"Leukemia","level":"3A","drugs":"Ruxolitinib","pmids":"22899477, 25207766, 26202607, 23630205, 22875628, 25515960, 23400675, 25260694","abstracts":""},{"isoform":"ENST00000360948","refSeq":"NM_001012338.2","entrezGeneId":4916,"gene":"NTRK3","variant":"G623R","cancerType":"All Tumors","level":"4","drugs":"LOXO-195","pmids":"28578312","abstracts":""},{"isoform":"ENST00000369535","refSeq":"NM_002524.4","entrezGeneId":4893,"gene":"NRAS","variant":"Oncogenic Mutations","cancerType":"Thyroid Cancer","level":"3A","drugs":"Selumetinib + Radioiodine Uptake Therapy","pmids":"22105174, 23406027","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Oncogenic Mutations","cancerType":"Melanoma","level":"2A","drugs":"Imatinib","pmids":"23775962, 18235121, 12181401, 21642685, 16098458, 15451219","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"G370C","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650N","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466A","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000257904","refSeq":"NM_000075.3","entrezGeneId":1019,"gene":"CDK4","variant":"Amplification","cancerType":"Dedifferentiated Liposarcoma","level":"2A","drugs":"Abemaciclib, Palbociclib","pmids":"23569312, 20601955, 26324739, 21610706","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1008_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 19 insertion","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"22190593","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816G","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000368508","refSeq":"NM_002944.2","entrezGeneId":6098,"gene":"ROS1","variant":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib","pmids":"25264305","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816E","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000358273","refSeq":"NM_001042492.2","entrezGeneId":4763,"gene":"NF1","variant":"Oncogenic Mutations","cancerType":"All Tumors","level":"4","drugs":"LTT462, Binimetinib, BVD523, Trametinib","pmids":"24576830, 26925841, 26936308, 23614898, 24535670","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X963_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Fusions","cancerType":"Myeloproliferative Neoplasm","level":"1","drugs":"Imatinib","pmids":"12944919, 17555450, 12660384, 16498388, 14504092, 16845659, 15034867","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"Exon 17 mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Sorafenib","pmids":"23140824, 22270258","abstracts":"Kindler et al. Abstract# 10009, ASCO 2011 http://meetinglibrary.asco.org/content/80567-102"},{"isoform":"ENST00000361445","refSeq":"NM_004958.3","entrezGeneId":2475,"gene":"MTOR","variant":"S2215F","cancerType":"Renal Clear Cell Carcinoma","level":"4","drugs":"Temsirolimus, Everolimus","pmids":"27482884","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600R","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Vemurafenib, Dabrafenib","pmids":"27080216, 20818844, 22743296, 26776917, 25466451, 26287849, 23733758, 26200454, 24888229, 25089220","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010H","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600M","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1007_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","cancerType":"Myeloproliferative Neoplasm","level":"1","drugs":"Imatinib","pmids":"16960151, 12676775, 12181402, 24963404, 14504092, 18950453, 24687085, 22897847, 1516603","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","cancerType":"Histiocytosis","level":"1","drugs":"Vemurafenib","pmids":"26287849, 29188284","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594N","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010Y","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000307102","refSeq":"NM_002755.3","entrezGeneId":5604,"gene":"MAP2K1","variant":"Oncogenic Mutations","cancerType":"Histiocytic Disorder","level":"3A","drugs":"Cobimetinib, Trametinib","pmids":"25351745, 26324360, 26566875, 25370473","abstracts":"Papapanagiotou et al. JCOPO, 2017 http://ascopubs.org/doi/full/10.1200/PO.16.00070"},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816A","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"F595L","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1009_splice","cancerType":"Non-Small Cell Lung Cancer","level":"2A","drugs":"Crizotinib","pmids":"25971939, 26729443, 25971938, 15735036, 26215952, 16397241, 19096300","abstracts":""},{"isoform":"ENST00000269571","refSeq":"NM_004448.2","entrezGeneId":2064,"gene":"ERBB2","variant":"Amplification","cancerType":"Breast Cancer","level":"1","drugs":"Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-Trastuzumab Emtansine, Lapatinib, Trastuzumab","pmids":"10561337, 21768458, 22149875, 16236738, 19060928, 19786658, 11248153, 17591827, 16452222, 16236737, 22153890, 22257673, 23020162, 16091755, 23602601, 20730488, 23871490, 17192538","abstracts":""},{"isoform":"ENST00000298552","refSeq":"NM_000368.4","entrezGeneId":7248,"gene":"TSC1","variant":"Oncogenic Mutations","cancerType":"Renal Cell Carcinoma","level":"2A","drugs":"Everolimus","pmids":"26831717","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816N","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"V654A","cancerType":"Gastrointestinal Stromal Tumor","level":"1","drugs":"Regorafenib, Sunitinib","pmids":"17046465, 19282169, 25641662, 23177515","abstracts":""},{"isoform":"ENST00000263967","refSeq":"NM_006218.2","entrezGeneId":5290,"gene":"PIK3CA","variant":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"Buparlisib, Serabelisib, Alpelisib + Fulvestrant, Copanlisib, GDC-0077, Taselisib + Fulvestrant, Alpelisib, Buparlisib + Fulvestrant, Taselisib","pmids":"28490463, 25877889, 22049316, 24652201, 23662903, 24608574, 22188813, 27672108, 25172762","abstracts":"Edgar et al. Abstract# 156, AACR 2017 http://cancerres.aacrjournals.org/content/77/13_Supplement/156; Di Leo et al. Abstract# S4-07, SABCS 2016 http://cancerres.aacrjournals.org/content/77/4_Supplement/S4-07; Wade et al. Abstract# 9054, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.15_suppl.9054; Juric et al. Abstract# 334, MBCC 2016 http://www.onclive.com/conference-coverage/mbcc-2016/alpelisib-combo-promising-in-pik3ca-altered-heavily-pretreated-breast-cancer; Juric et al. Abstract# 334, MBCC 2016 http://www.onclive.com/conference-coverage/mbcc-2016/alpelisib-combo-promising-in-pik3ca-altered-heavily-pretreated-breast-cancer; Di Leo et al. Abstract# S4-07, SABCS 2016 http://cancerres.aacrjournals.org/content/77/4_Supplement/S4-07; Dickler et al. Abstract# 520, ASCO 2016 http://meetinglibrary.asco.org/content/165518-176"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1006_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816H","cancerType":"Gastrointestinal Stromal Tumor","level":"4","drugs":"Avapritinib, DCC-2618","pmids":"28077435","abstracts":""},{"isoform":"ENST00000391945","refSeq":"NM_000400.3","entrezGeneId":2068,"gene":"ERCC2","variant":"Oncogenic Mutations","cancerType":"Bladder Cancer","level":"3A","drugs":"Cisplatin","pmids":"12208738, 25096233, 27310333","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"981_1028splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000278616","refSeq":"NM_000051.3","entrezGeneId":472,"gene":"ATM","variant":"Truncating Mutations","cancerType":"Prostate Cancer","level":"4","drugs":"Olaparib","pmids":"26510020","abstracts":""},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"D1010N","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D594A","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G466A","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000257290","refSeq":"NM_006206.4","entrezGeneId":5156,"gene":"PDGFRA","variant":"Oncogenic Mutations","cancerType":"Gastrointestinal Stromal Tumor","level":"2A","drugs":"Imatinib","pmids":"24963404, 15928335","abstracts":""},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","cancerType":"All Solid Tumors","level":"1","drugs":"Pembrolizumab","pmids":"26028255","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"K601E","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 28344857, 24933606, 23248257","abstracts":""},{"isoform":null,"refSeq":null,"entrezGeneId":-2,"gene":"Other Biomarkers","variant":"Microsatellite Instability-High","cancerType":"Colorectal Cancer","level":"1","drugs":"Nivolumab","pmids":"23169436, 28223062","abstracts":"Overman et al. Abstract# 3501, ASCO 2016 http://meetinglibrary.asco.org/content/166455-176, PMID: 28223062"},{"isoform":"ENST00000397752","refSeq":"NM_000245.2","entrezGeneId":4233,"gene":"MET","variant":"X1009_splice","cancerType":"Non-Small Cell Lung Cancer","level":"3A","drugs":"Cabozantinib, Capmatinib","pmids":"21918175, 25971939, 25971938, 27693535","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"G469V","cancerType":"Melanoma","level":"4","drugs":"Trametinib","pmids":"26343582, 28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600K","cancerType":"Melanoma","level":"1","drugs":"Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib","pmids":"23846731, 22735384, 25265494, 25287827, 25399551, 22608338, 23051966, 23918947, 20818844, 22663011, 25265492, 24508103, 23020132, 25089220","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816Y","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000524377","refSeq":"NM_002529.3","entrezGeneId":4914,"gene":"NTRK1","variant":"G595R","cancerType":"All Tumors","level":"4","drugs":"LOXO-195","pmids":"28578312","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"L597R","cancerType":"Melanoma","level":"3A","drugs":"Trametinib","pmids":"22798288, 24933606","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"D287H","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"Exon 20 insertion","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"AP32788","pmids":"","abstracts":"Gonzalvez, F. et al. Abstract# 2644, AACR Annual Meeting 2016 http://cancerres.aacrjournals.org/content/76/14_Supplement/2644"},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172S","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"27292784, 28588020, 26553750","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600G","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000371953","refSeq":"NM_000314.4","entrezGeneId":5728,"gene":"PTEN","variant":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"4","drugs":"AZD6482 + Alpelisib","pmids":"25409150","abstracts":""},{"isoform":"ENST00000288135","refSeq":"NM_000222.2","entrezGeneId":3815,"gene":"KIT","variant":"D816F","cancerType":"Thymic Tumor","level":"2A","drugs":"Sunitinib, Sorafenib","pmids":"25592632, 19461405, 20571495","abstracts":""},{"isoform":"ENST00000349310","refSeq":"NM_001014431.1","entrezGeneId":207,"gene":"AKT1","variant":"E17K","cancerType":"Endometrial Cancer","level":"3A","drugs":"AZD5363","pmids":"22294718, 23394218, 28489509, 26351323","abstracts":""},{"isoform":"ENST00000524377","refSeq":"NM_002529.3","entrezGeneId":4914,"gene":"NTRK1","variant":"G667C","cancerType":"All Tumors","level":"4","drugs":"LOXO-195","pmids":"28578312","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"Fusions","cancerType":"Bladder Cancer","level":"3A","drugs":"AZD4547, JNJ-42756493, BGJ398, Debio1347","pmids":"26324363, 22837387","abstracts":""},{"isoform":"ENST00000261799","refSeq":"NM_002609.3","entrezGeneId":5159,"gene":"PDGFRB","variant":"Fusions","cancerType":"Myelodysplasia","level":"1","drugs":"Imatinib","pmids":"16960151, 12676775, 12181402, 24963404, 14504092, 18950453, 24687085, 22897847, 1516603","abstracts":""},{"isoform":"ENST00000524377","refSeq":"NM_002529.3","entrezGeneId":4914,"gene":"NTRK1","variant":"Fusions","cancerType":"All Solid Tumors","level":"3A","drugs":"Larotrectinib, Entrectinib","pmids":"26216294, 28183697","abstracts":"Pishvaian et al. Abstract# 521, Gastrointestinal Cancer Symposium, 2018 https://meetinglibrary.asco.org/record/155954/abstract; Hyman et al. Abstract# LBA2501, ASCO 2017 http://ascopubs.org/doi/abs/10.1200/JCO.2017.35.18_suppl.LBA2501"},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"F595L","cancerType":"Non-Small Cell Lung Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"N581S","cancerType":"Colorectal Cancer","level":"4","drugs":"RTK-Inhibitor + Trametinib","pmids":"28783719","abstracts":""},{"isoform":"ENST00000275493","refSeq":"NM_005228.3","entrezGeneId":1956,"gene":"EGFR","variant":"G719A","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Erlotinib, Afatinib, Gefitinib","pmids":"21531810, 15638953, 14570950, 15118073, 26051236, 21670455, 18408761, 16011858, 16187797, 24285021, 20573926","abstracts":""},{"isoform":"ENST00000288602","refSeq":"NM_004333.4","entrezGeneId":673,"gene":"BRAF","variant":"V600E","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Dabrafenib + Trametinib","pmids":"22663011, 27283860, 25089220","abstracts":""},{"isoform":"ENST00000256078","refSeq":"NM_033360.2","entrezGeneId":3845,"gene":"KRAS","variant":"Oncogenic Mutations","cancerType":"Colorectal Cancer","level":"R1","drugs":"Panitumumab, Cetuximab","pmids":"21228335, 20619739, 18316791, 20921465, 24024839","abstracts":""},{"isoform":"ENST00000389048","refSeq":"NM_004304.4","entrezGeneId":238,"gene":"ALK","variant":"Fusions","cancerType":"Non-Small Cell Lung Cancer","level":"1","drugs":"Crizotinib, Brigatinib, Alectinib, Ceritinib","pmids":"25322323, 24670165, 26708155, 26598747, 21502504, 26973324, 27836716, 23724913","abstracts":"Kim et al. Abstract# 9007, ASCO 2016 http://meetinglibrary.asco.org/content/165056-176"},{"isoform":"ENST00000206249","refSeq":"NM_001122740.1","entrezGeneId":2099,"gene":"ESR1","variant":"Oncogenic Mutations","cancerType":"Breast Cancer","level":"3A","drugs":"AZD9496, Fulvestrant","pmids":"27986707, 27269946","abstracts":""},{"isoform":"ENST00000260795","refSeq":"NM_000142.4","entrezGeneId":2261,"gene":"FGFR3","variant":"K650R","cancerType":"Bladder Cancer","level":"3A","drugs":"BGJ-398, JNJ-42756493, AZD-4575, Debio1347","pmids":"21119661, 26324363, 27870574","abstracts":""},{"isoform":"ENST00000330062","refSeq":"NM_002168.2","entrezGeneId":3418,"gene":"IDH2","variant":"R172K","cancerType":"Acute Myeloid Leukemia","level":"1","drugs":"Enasidenib","pmids":"27292784, 28588020, 26553750","abstracts":""}]